A61K 31/325
Carbamic acids
Official title: Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof (thiurams A61K31/145)
A61K31/325 (Carbamic acids) appears on 360 US grants and 592 published applications in this corpus.
Search patents in A61K- Granted patents
- 360
- Published applications
- 592
- Assignees
- 305
- Inventors
- 1,060
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 4 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 5 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 5 | 0 |
| 1998 | 14 | 0 |
| 1999 | 3 | 0 |
| 2000 | 5 | 0 |
| 2001 | 3 | 4 |
| 2002 | 7 | 12 |
| 2003 | 10 | 20 |
| 2004 | 7 | 24 |
| 2005 | 1 | 17 |
| 2006 | 5 | 28 |
| 2007 | 5 | 25 |
| 2008 | 2 | 10 |
| 2009 | 4 | 16 |
| 2010 | 8 | 14 |
| 2011 | 11 | 21 |
| 2012 | 6 | 14 |
| 2013 | 11 | 27 |
| 2014 | 11 | 34 |
| 2015 | 18 | 33 |
| 2016 | 22 | 37 |
| 2017 | 26 | 38 |
| 2018 | 18 | 24 |
| 2019 | 31 | 38 |
| 2020 | 26 | 29 |
| 2021 | 23 | 33 |
| 2022 | 9 | 20 |
| 2023 | 18 | 24 |
| 2024 | 17 | 13 |
| 2025 | 6 | 21 |
| 2026 | 5 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Extended-release pharmaceutical compositions of Ralinepag24 Mar 2026US 12,582,629 B1Innovate Therapeutics LLC
- Compositions and methods for treating cancer with atypical BRAF mutations24 Mar 2026US 12,582,635 B2Biomed Valley Discoveries, Inc.
- Combinational therapy of LSD1 inhibitors with P21 activators in the treatment of cancer17 Mar 2026US 12,576,083 B2Istituto Europeo di Oncologia S.r.l.
- Composition for inhibiting cancer metastasis and treating cancer3 Feb 2026US 12,539,297 B2Oncocross Co., Ltd.
- Methods for objective assessment of stress, early detection of risk for stress disorders, matching individuals with treatments, monitoring response to treatment, and new methods of use for drugs20 Jan 2026US 12,529,704 B2Indiana University Research and Technology Corporation
- Ketamine for the treatment of menstrually related symptoms1 Oct 2026US 2026/0294843 A1
- Stat3 inhibitor to treat subarachnoid hemorrhage24 Sep 2026US 2026/0283999 A1
- Carbamoyl phenylalaninol compounds as taar1 agonists3 Sep 2026US 2026/0256729 A1Axsome Therapeutics, Inc.
- U-p53 peptides as markers in the rate of progression of cognitive decline to alzheimer's disease13 Aug 2026US 2026/0235628 A1
- Protease inhibitors for treating or preventing coronavirus infection23 Jul 2026US 2026/0209180 A1Merck Sharp & Dohme Corp.
Most cited
By later US patents
- Lipid containing formulations152US 8,642,076 B2Tekmira Pharmaceuticals Corporation · 2014
- Dietary composition for enhancing metabolism and alleviating oxidative stress69US 5,916,912 AThe Regents of the University of California · 1999
- Treatment of cataplexy69US 9,359,290 B2Jazz Pharmaceuticals International III Limited · 2016
- Process and composition for high efficacy teeth whitening64US 6,365,134 B1Scientific Pharmaceuticals, Inc. · 2002
- Treatment for atherosclerosis and other cardiovascular and inflammatory diseases63US 5,380,747 AEmory University · 1995